SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
DIGITAL ANGEL CORPORATION
( FORMERLY MEDICAL ADVISORY SYSTEMS, INC.)
(Name of Issuer)
Common Stock
(Title of Class of Securities)
58449P 10 1
(CUSIP Number)
James H. Carll, Esq.
Archer & Greiner
One Centennial Square
Haddonfield, NJ 08033
(856-795-2121)
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
May 1, 2002
(Date of Event which Requires
Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-l(b)(3) or (4), check the following box [ ].
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on the following pages)
Page 1
--------------------------------------------------------------------------------
CUSIP NO. 58449P 10 1
--------------------------------------------------------------------------------
1) Name of Reporting Person
S.S. or I.R.S. Identification Nos. of Above Person
eResearchTechnology, Inc
--------------------------------------------------------------------------------
2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [x]
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Source of Funds (See Instructions)
WC
--------------------------------------------------------------------------------
5) Check if Disclosure of Legal Proceedings is
Required Pursuant to Items 2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6) Citizenship or Place of Organization
State of Delaware
--------------------------------------------------------------------------------
Number of Shares (7) Sole Voting Power 375,025
Beneficially --------------------------------------------------------------
Owned By Each
Reporting (8) Shared Voting Power Zero
Person --------------------------------------------------------------
With
(9) Sole Dispositive Power 375,025
--------------------------------------------------------------
(10) Shared Dispositive Power Zero
--------------------------------------------------------------
11) Aggregate Amount Beneficially Owned by Each Reporting Person
375,025
--------------------------------------------------------------------------------
12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) [ ]
--------------------------------------------------------------------------------
13) Percent of Class Represented by Amount in Row (11)
1.6%
--------------------------------------------------------------------------------
14) Type of Reporting Person (See Instructions)
CO
--------------------------------------------------------------------------------
2
The Statement on Schedule 13-D dated March 30, 2000, as heretofore
amended (the "Schedule 13-D"), is hereby amended as follows:
Item 4 - Purpose of Transactions.
Item 4 of the Schedule 13-D is hereby amended by adding the following
additional paragraph:
The Reporting Person intends to liquidate its remaining shares of the
Common Stock of the Issuer. The timing of these sales will be based upon market
and business conditions and other factors.
Item 5- Interest in Securities of the Issuer.
Item 5 of the Schedule 13-D is hereby amended to read in its entirety
as follows:
The Reporting Person owns 375,025 shares of the Common Stock,
representing 1.6% of the outstanding Common Stock (such percentage being based
upon the outstanding shares as indicated in Issuer's most recent available
filing with the Securities and Exchange Commission). The Reporting Person
possesses the sole power to vote or to direct the vote and to dispose or to
direct the disposition of all shares of Common Stock owned by it.
To the best knowledge of the Reporting Person, none of the persons
listed in Item 2 to the Schedule 13-D beneficially owns any shares of Common
Stock.
The Reporting Person made, during the period following the date of
Amendment No. 1 to the Schedule 13-D to the date of this Amendment No. 2, market
sales of the Common Stock as described on Schedule I hereto. Such sales were
effectuated on the books of the Issuer on May 1, 2002.
Due to the issuance of additional shares by the Issuer, the Reporting
Person ceased being the beneficial owner of more than 5% of the Common Stock on
March 27, 2002.
3
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: May 1, 2002 eResearchTechnology, Inc.
By: /s/ Bruce Johnson
------------------------------
Bruce Johnson
Senior Vice President and
Chief Financial Officer
4
SCHEDULE I
Market Sales of Common Stock
During the period from the date of Amendment No. 1 to Schedule 13-D to
the date of Amendment No. 2 to Schedule 13-D, eResearchTechnology, Inc effected
the following sales of Common Stock in market transactions by brokers acting on
its behalf:
---------------------------------------- ------------------------------------ --------------------------------------
Date No. of Shares Price Per Share
---------------------------------------- ------------------------------------ --------------------------------------
4/2/02 13,900 $5.4051
---------------------------------------- ------------------------------------ --------------------------------------
4/3/02 4,500 5.0244
---------------------------------------- ------------------------------------ --------------------------------------
4/4/02 14,900 5.0688
---------------------------------------- ------------------------------------ --------------------------------------
4/5/02 1,000 4.70
---------------------------------------- ------------------------------------ --------------------------------------
4/8/02 6,500 4.046
---------------------------------------- ------------------------------------ --------------------------------------
4/9/02 46,200 4.0274
---------------------------------------- ------------------------------------ --------------------------------------
4/10/02 20,000 4.1424
---------------------------------------- ------------------------------------ --------------------------------------
4/11/02 2,000 4.10
---------------------------------------- ------------------------------------ --------------------------------------